FDA Cracks Down on Indian Companies Making US-Bound Meds
FDA investigators have stepped up investigations of Indian drug manufacturers and issued "a flood" of warning letters and fines for providing falsified drug test results and selling fake medications.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.